2
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Treatment with H2-Receptor Antagonists: When Is the Best Time to Dose?

, &
Pages 15-22 | Published online: 08 Jul 2009
 

Abstract

Antisecretory drugs such as H2-receptor antagonists or H+K+-ATPase inhibitors heal acid-related lesions of the upper gastrointestinal tract, largely through their ability to reduce gastric acid secretion, and the clinical outcome with different compounds parallels the degree and duration of inhibition. The practice of administering H2-receptor antagonists at bedtime is empirical, and it has been suggested that a change in time of drug intake or increase in dose would optimize pharmacodynamic and clinical results. Whilst pharmacodynamic studies with the more potent drugs given after the evening meal yield superior intragastric pH control, this was less consistently reflected in the healing rates in duodenal ulcer trials. These results indicate that early evening dosing provides an effective alternative to the standard treatment regimens and further improvements may be obtainable by the use of increased doses of the available potent H2-receptor antagonists.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.